Le Lézard20m
Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligencetm Platform
Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application directed ...
Le Lézard28m
Statement from the ALS Association: Proposed Funding Cuts Will Derail Efforts to Turn ALS from Fatal to Livable
We are deeply alarmed by proposed cuts to research that will deal a devastating blow to the fight against ALS. Drastic changes to research funding will hinder progress toward turning ALS from fatal to ...